Dezhan Healthcare Co (SZSE:000813) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:000813 Dezhan Healthcare Co Ltd SZSE:000813
61 GF Score
Price ¥3.38
GF Value ¥2.71
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Dezhan Healthcare Co FFO?

FFO (Funds from operations) only applies to REITs.

SZSE:000813
61GF Score
Dezhan Healthcare Co Ltd SZSE:000813
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Dezhan Healthcare Co (SZSE:000813) Overvalued in 2026?

Based on GuruFocus' analysis, Dezhan Healthcare Co stock appears to be overvalued. The current stock price of ¥3.38 is trading 24.7% above its estimated GF Value™ of ¥2.71. GuruFocus considers Dezhan Healthcare Co to be Modestly Overvalued.

Key valuation signals for SZSE:000813:

  • FFO:
  • GF Value™: ¥2.71 vs. price of ¥3.38 (24.7% above fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the SZSE:000813 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dezhan Healthcare Co Business Description

Address No. 235 Yin Chuan Road, Xinjiang, Urumqi, CHN, 830054
Dezhan Healthcare Co Ltd's main business is drug research and development, production, and sales. The company's wholly-owned subsidiary Jialin Pharmaceuticals mainly engages in the research and development, production, and sale of cardiovascular drugs, the drugs being produced and sold including Ale (10mg), Alle (20mg), hydrochloric acid quercetine capsules, Van Le tablets type 1, Van Le tablets.
61GF Score

Get the complete analysis for SZSE:000813

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥3.38
Price
¥2.71
GF Value